Sign inGet started

Jermasek Douglas

Insider CIK 1955273 · UNCY EVP, Corporate Strategy

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
UNCY Unicycive Therapeutics, In A Award deriv2026-05-142026-05-20169,500— $0169,500SEC↗
UNCY Unicycive Therapeutics, In A Award deriv2026-05-142026-06-15169,500— $0169,500SEC↗
UNCY Unicycive Therapeutics, In A Award deriv2025-07-282025-07-3010,000— $0215,500SEC↗
UNCY Unicycive Therapeutics, In A Award deriv2024-08-122024-08-1481,750— $02,055,000SEC↗
UNCY Unicycive Therapeutics, In A Award deriv2024-04-152024-04-17463,250— $01,973,250SEC↗
UNCY Unicycive Therapeutics, In A Award deriv2023-08-282023-08-301,355,000— $01,510,000SEC↗
UNCY Unicycive Therapeutics, In M Exercise deriv2023-07-112023-07-1372,047— $072,047SEC↗
UNCY Unicycive Therapeutics, In M Exercise deriv2023-07-112023-07-1379,252— $079,252SEC↗
UNCY Unicycive Therapeutics, In M Exercise deriv2023-07-112023-07-13115,275— $0115,275SEC↗
UNCY Unicycive Therapeutics, In M Exercise deriv2023-07-112023-07-1350$1000.00 $50.0K0SEC↗
UNCY Unicycive Therapeutics, In M Exercise2023-07-112023-07-13104,612— $0175,012SEC↗
UNCY Unicycive Therapeutics, In A Award deriv2023-03-082023-03-0950$1000.00 $50.0K50SEC↗
UNCY Unicycive Therapeutics, In A Award deriv2022-11-212022-11-2355,000— $0155,000SEC↗